Literature DB >> 23355471

The allosteric mechanism induced by protein kinase A (PKA) phosphorylation of dematin (band 4.9).

Lin Chen1, Jeffrey W Brown, Yee-Foong Mok, Danny M Hatters, C James McKnight.   

Abstract

Dematin (band 4.9) is an F-actin binding and bundling protein best known for its role within red blood cells, where it both stabilizes as well as attaches the spectrin/actin cytoskeleton to the erythrocytic membrane. Here, we investigate the structural consequences of phosphorylating serine 381, a covalent modification that turns off F-actin bundling activity. In contrast to the canonical doctrine, in which phosphorylation of an intrinsically disordered region/protein confers affinity for another domain/protein, we found the converse to be true of dematin: phosphorylation of the well folded C-terminal villin-type headpiece confers affinity for its intrinsically disordered N-terminal core domain. We employed analytical ultracentrifugation to demonstrate that dematin is monomeric, in contrast to the prevailing view that it is trimeric. Next, using a series of truncation mutants, we verified that dematin has two F-actin binding sites, one in the core domain and the other in the headpiece domain. Although the phosphorylation-mimicking mutant, S381E, was incapable of bundling microfilaments, it retains the ability to bind F-actin. We found that a phosphorylation-mimicking mutant, S381E, eliminated the ability to bundle, but not bind F-actin filaments. Lastly, we show that the S381E point mutant caused the headpiece domain to associate with the core domain, leading us to the mechanism for cAMP-dependent kinase control of dematin's F-actin bundling activity: when unphosphorylated, dematin's two F-actin binding domains move independent of one another permitting them to bind different F-actin filaments. Phosphorylation causes these two domains to associate, forming a compact structure, and sterically eliminating one of these F-actin binding sites.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355471      PMCID: PMC3605649          DOI: 10.1074/jbc.M112.438861

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Marie Unna hereditary hypotrichosis gene maps to human chromosome 8p21 near hairless.

Authors:  G P Sreekumar; J L Roberts; C Q Wong; K S Stenn; S Parimoo
Journal:  J Invest Dermatol       Date:  2000-03       Impact factor: 8.551

2.  Why are "natively unfolded" proteins unstructured under physiologic conditions?

Authors:  V N Uversky; J R Gillespie; A L Fink
Journal:  Proteins       Date:  2000-11-15

3.  Determination of the sedimentation coefficient distribution by least-squares boundary modeling.

Authors:  P Schuck; P Rossmanith
Journal:  Biopolymers       Date:  2000-10-15       Impact factor: 2.505

4.  Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography.

Authors:  Andrea Nans; Narla Mohandas; David L Stokes
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

5.  A method for efficient isotopic labeling of recombinant proteins.

Authors:  J Marley; M Lu; C Bracken
Journal:  J Biomol NMR       Date:  2001-05       Impact factor: 2.835

6.  Identification of a novel role for dematin in regulating red cell membrane function by modulating spectrin-actin interaction.

Authors:  Ichiro Koshino; Narla Mohandas; Yuichi Takakuwa
Journal:  J Biol Chem       Date:  2012-08-26       Impact factor: 5.157

7.  Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.

Authors:  C D Vocke; R O Pozzatti; D G Bostwick; C D Florence; S B Jennings; S E Strup; P H Duray; L A Liotta; M R Emmert-Buck; W M Linehan
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

8.  Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression.

Authors:  M Lutchman; S Pack; A C Kim; A Azim; M Emmert-Buck; C van Huffel; Z Zhuang; A H Chishti
Journal:  Cancer Genet Cytogenet       Date:  1999-11

9.  Identifying competitive protein antagonists for F-actin with reverse-phase high-performance liquid chromatography.

Authors:  Jeffrey W Brown; C James McKnight
Journal:  Anal Biochem       Date:  2009-11-20       Impact factor: 3.365

10.  An atomic model of actin filaments cross-linked by fimbrin and its implications for bundle assembly and function.

Authors:  N Volkmann; D DeRosier; P Matsudaira; D Hanein
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more
  5 in total

1.  Phosphorylated and unphosphorylated serine 13 of CDC37 stabilize distinct interactions between its client and HSP90 binding domains.

Authors:  Wenjun Liu; Ralf Landgraf
Journal:  Biochemistry       Date:  2015-02-11       Impact factor: 3.162

2.  Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia.

Authors:  Yunzhe Lu; Toshihiko Hanada; Yuko Fujiwara; Jennifer O Nwankwo; Adam J Wieschhaus; John Hartwig; Sha Huang; Jongyoon Han; Athar H Chishti
Journal:  Blood       Date:  2016-04-12       Impact factor: 22.113

3.  cAMP-Signalling Regulates Gametocyte-Infected Erythrocyte Deformability Required for Malaria Parasite Transmission.

Authors:  Ghania Ramdani; Bernina Naissant; Eloise Thompson; Florence Breil; Audrey Lorthiois; Florian Dupuy; Ross Cummings; Yoann Duffier; Yolanda Corbett; Odile Mercereau-Puijalon; Kenneth Vernick; Donatella Taramelli; David A Baker; Gordon Langsley; Catherine Lavazec
Journal:  PLoS Pathog       Date:  2015-05-07       Impact factor: 6.823

4.  abLIM1 constructs non-erythroid cortical actin networks to prevent mechanical tension-induced blebbing.

Authors:  Guoqing Li; Shan Huang; Sen Yang; Jiabin Wang; Jingli Cao; Daniel M Czajkowsky; Zhifeng Shao; Xueliang Zhu
Journal:  Cell Discov       Date:  2018-07-24       Impact factor: 10.849

Review 5.  Digested disorder: Quarterly intrinsic disorder digest (January/February/March, 2013).

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2013-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.